Study shows epidurals don't slow labor

October 10, 2017, Beth Israel Deaconess Medical Center
Credit: CC0 Public Domain

Epidural analgesia - a mix of anesthetics and narcotics delivered by catheter placed close to the nerves of the spine - is the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have long been thought to slow the second stage of labor - defined as beginning when the cervix is completely dilated and ending when the baby is delivered. Because a longer duration of this stage of labor is associated with adverse outcomes, obstetricians routinely reduce or discontinue epidural pain management in an effort to expedite this main stage of labor.

That practice could be out-of-date and misguided, according to research led by scientists at Beth Israel Deaconess Medical Center (BIDMC). A paper published today in the journal Obstetrics & Gynecology demonstrated that medication had no effect on the duration of the second stage of , normal vaginal delivery rate, incidence of episiotomy, the position of the fetus at birth or any other measure of fetal well-being the researchers investigated. The study compared the effects of catheter-infused, low-concentration epidural anesthetic to a catheter-infused saline placebo in this double-blinded, randomized trial of 400 women.

"We found that exchanging the epidural anesthetic with a saline placebo made no difference in the duration of the second stage of labor," said senior author Philip E. Hess, MD, Director of Obstetric Anesthesia at BIDMC and Associate Professor of Anaesthesia and of Obstetrics at Harvard Medical School. "Not even the scores were statistically different between groups. However, pain scores in women receiving the saline placebo increased over time, as would be expected."

The study enrolled healthy, first-time mothers who were provided with a patient-controlled epidural analgesic pump in the first stage of labor. All mothers were given active pain medication during this early stage of labor.

When they reached the second stage of labor, participants were randomized to receive either the active anesthetic (low doses of the drugs ropivacaine and sufentanil) or the saline placebo. In this stage of labor, none of the mothers, investigators, obstetricians or midwives knew whether the catheter-delivered infusions contained the active pain medication or the saline placebo in this double-blind clinical trial.

Women in excessive pain were given unblinded doses of the active pain medication at their doctors' discretion and doctors could also terminate epidural infusions at any time based on clinical indicators.

The primary outcome, the duration of the second stage of labor, was similar between both groups: about 52 minutes for women given active pain medication versus about 51 minutes for women given the saline - just a 3.3 percent difference. The median times were also similar: 45 minutes for women on active pain medication versus 46 for those on saline. Of note, obstetricians requested to stop epidural infusions in 38 patients for poor progression of labor. Of these, 17 of the women were in the saline group. Twenty-one were in the active group.

In addition to the duration of the second stage of labor, Hess and his colleagues looked at a variety of outcomes measuring fetal health and well-being, such as birth weight, Apgar scores - a quick measure of fetal health taken minutes after birth - and umbilical artery pH, a metric for assessing fetal blood oxygen levels. The team also compared patient-reported and patient satisfaction with pain control measures.

"Twice as many given the placebo reported lower satisfaction with their pain relief compared to those provided the anesthetic," said Hess. "Ethically, if epidural medications result in a negative effect on the second stage of labor, one could argue that a mild increase in maternal pain could be balanced by a successful vaginal delivery. We didn't see any negative effects, but epidural analgesia in the second of labor remains controversial and merits follow up studies."

Explore further: Patient-controlled analgesia not as effective as epidural for labor pain

Related Stories

Patient-controlled analgesia not as effective as epidural for labor pain

February 3, 2014
In a study to be presented on Feb. 7 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report findings which suggest remifentanil patient controlled analgesia ...

Easing labor pain may help reduce postpartum depression in some women, early research suggests

October 26, 2016
Epidural anesthesia may do more than relieve pain during labor; in some women it may decrease the likelihood of postpartum depression, suggests a preliminary study presented at the ANESTHESIOLOGY 2016 annual meeting.

Women who opt for laughing gas during labor, may still get an epidural, study shows

October 24, 2016
The majority of women who chose nitrous oxide (laughing gas) to manage labor pain, ultimately decide to have an epidural, according to new research presented at the Anesthesiology 2016 annual meeting. Researchers found nitrous ...

Combo treatment might beat epidural to ease labor, study says

March 5, 2013
(HealthDay)—In the first stage of labor, a combined spinal-epidural technique provides faster and better pain relief compared to traditional epidural pain relief, a new study suggests.

Fetal decent and maternal feedback substantially shortens second stage labor

February 2, 2015
In a study to be presented on Feb. 5 in an oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report that the use of a system that provides ...

Recommended for you

New study reveals time and day women are most likely to give birth

June 15, 2018
A new study has found that the time and day that women give birth can vary significantly depending on how labour starts and the mode of giving birth.

Blood test for pregnant women can predict premature birth

June 7, 2018
A new blood test for pregnant women detects with 75-80 percent accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus's gestational age—or the mother's due date—as ...

Drug combination offers more effective care for patients suffering miscarriage

June 6, 2018
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage ...

Genes, environment and schizophrenia—new study finds the placenta is the missing link

May 28, 2018
Hiding in plain sight, new research shines a spotlight on the placenta's critical role in the nature versus nurture debate and how it confers risk for schizophrenia and likely other neurodevelopmental disorders including ...

Vendors say pot eases morning sickness. Will baby pay a price?

May 22, 2018
(HealthDay)—Nearly 70 percent of Colorado marijuana dispensaries recommended pot products to manage early pregnancy-related morning sickness, new research reveals.

Pregnancy drug DES might have triggered ADHD in the grandchildren of women who used it

May 21, 2018
A study conducted by researchers at Columbia University's Mailman School of Public Health and Harvard T.H. Chan School of Public Health reported elevated odds for attention deficit hyperactivity disorder (ADHD) in the grandchildren ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.